Methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
C46H58N10O6S — CID 118876204
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
Methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate (PubChem CID 118876204) has the molecular formula C46H58N10O6S and a molecular weight of 879.10 g/mol. Its IUPAC name is methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
|---|---|
| PubChem CID | 118876204 |
| Molecular Formula | C46H58N10O6S |
| Molecular Weight | 879.10 g/mol |
| Exact Mass | 878.43 |
| IUPAC Name | methyl N-[(2S)-1-[(2S)-2-[6-[(2R,5R)-5-[2-[(2S)-1-(2-carbamoyloxy-3-methylbutanoyl)pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-1-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)pyrrolidin-2-yl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate |
| SMILES | COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc([C@H]3CC[C@H](c4ccc5nc([C@@H]6CCCN6C(=O)C(OC(N)=O)C(C)C)[nH]c5c4)N3c3nc4c(s3)CCCC4)cc2[nH]1)C(C)C |
| InChI | InChI=1S/C46H58N10O6S/c1-24(2)38(53-46(60)61-5)42(57)54-20-8-11-35(54)40-48-28-16-14-26(22-31(28)50-40)33-18-19-34(56(33)45-52-30-10-6-7-13-37(30)63-45)27-15-17-29-32(23-27)51-41(49-29)36-12-9-21-55(36)43(58)39(25(3)4)62-44(47)59/h14-17,22-25,33-36,38-39H,6-13,18-21H2,1-5H3,(H2,47,59)(H,48,50)(H,49,51)(H,53,60)/t33-,34-,35+,36+,38+,39?/m1/s1 |
| InChIKey | PSJKYJMPRGIMEA-PGHIMURDSA-N |
| XLogP | 7.68 |
| TPSA | 204.76 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 879.10 |
| LogP ≤ 5 | 7.68 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118876204 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.